These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10460660)

  • 1. Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression.
    Iczkowski KA; Shanks JH; Allsbrook WC; Lopez-Beltran A; Pantazis CG; Collins TR; Wetherington RW; Bostwick DG
    Histopathology; 1999 Aug; 35(2):150-6. PubMed ID: 10460660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of CD44 variant 6 expression differentiates small cell carcinoma of urinary bladder from urothelial (transitional cell) carcinoma.
    Iczkowski KA; Shanks JH; Bostwick DG
    Histopathology; 1998 Apr; 32(4):322-7. PubMed ID: 9602328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse p16 and p63 expression in small cell carcinoma and high-grade urothelial cell carcinoma of the urinary bladder.
    Buza N; Cohen PJ; Pei Hui ; Parkash V
    Int J Surg Pathol; 2010 Apr; 18(2):94-102. PubMed ID: 20164052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach.
    Thompson S; Cioffi-Lavina M; Chapman-Fredricks J; Gomez-Fernandez C; Fernandez-Castro G; Jorda M
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):395-9. PubMed ID: 21617524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.
    Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M
    Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinosarcoma of the urinary bladder: a distinct variant characterized by small cell undifferentiated carcinoma with neuroendocrine features.
    Mazzucchelli L; Kraft R; Gerber H; Egger C; Studer UE; Zimmermann A
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(6):477-83. PubMed ID: 1281592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of p63 and high molecular weight cytokeratin in the distinction between urothelial carcinoma with prostatic stromal invasion and urothelial carcinoma with colonisation of prostatic ducts and acini.
    Chastain EC; Oliva IV; Osunkoya AO
    Pathology; 2012 Apr; 44(3):199-203. PubMed ID: 22406481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
    Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
    Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens.
    McKenney JK; Desai S; Cohen C; Amin MB
    Am J Surg Pathol; 2001 Aug; 25(8):1074-8. PubMed ID: 11474293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
    Oliva E; Amin MB; Jimenez R; Young RH
    Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small cell carcinoma of the urinary bladder. A clinicopathological study of six cases.
    Lopez JI; Angulo JC; Flores N; Toledo JD
    Br J Urol; 1994 Jan; 73(1):43-9. PubMed ID: 7507782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulinoma-associated Protein 1 (INSM1) Expression in Small Cell Neuroendocrine Carcinoma of the Urinary Tract.
    Kim IE; Amin A; Wang LJ; Cheng L; Perrino CM
    Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):687-693. PubMed ID: 31876605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical profile of urothelial and small cell carcinomas of the bladder.
    Fernández-Aceñero MJ; Córdova S; Manzarbeitia F; Medina C
    Pathol Oncol Res; 2011 Sep; 17(3):519-23. PubMed ID: 21203907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult urinary bladder tumors with rhabdomyosarcomatous differentiation: clinical, pathological and immunohistochemical studies.
    Bing Z; Zhang PJ
    Diagn Pathol; 2011 Jul; 6():66. PubMed ID: 21762516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromogranin, laminin and collagen type IV.
    Bjerkehagen B; Fosså SD; Raabe N; Holm R; Nesland JM
    Eur Urol; 1994; 26(4):334-9. PubMed ID: 7713133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary small cell neuroendocrine carcinoma of the urinary bladder: a clinicopathologic, immunohistochemical, and ultrastructural evaluation.
    Hussein MR; Al-Assiri M; Eid RA; Musalam AO
    Ultrastruct Pathol; 2010 Aug; 34(4):232-5. PubMed ID: 20594044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
    Ross JS; del Rosario AD; Bui HX; Kallakury BV; Okby NT; Figge J
    Mod Pathol; 1996 Aug; 9(8):854-60. PubMed ID: 8871928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing upper tract urothelial carcinoma diagnosis: Utility of cytokeratin 17 and CK20/CD44/p53 immunohistochemical panel.
    Irwin T; Donlan AW; Owens L; Alvarez R; Vakar-Lopez F; Tretiakova M
    Hum Pathol; 2024 Apr; 146():43-48. PubMed ID: 38593961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44v6 correlates with cell proliferation and cellular atypia in urothelial carcinoma cell lines 5637 and HT1197.
    Kuncová J; Kostrouch Z; Viale M; Revoltella R; Mandys V
    Folia Biol (Praha); 2005; 51(1):3-11. PubMed ID: 15783086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
    Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
    Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.